|
1
|
Clark WH Jr, From L, Bernardino EA and
Mihm MC: The histogenesis and biologic behavior of primary human
malignant melanomas of the skin. Cancer Res. 29:705–727.
1969.PubMed/NCBI
|
|
2
|
Clark WH Jr, Elder DE, Guerry D IV,
Braitman LE, Trock BJ, Schultz D, Synnestvedt M and Halpern AC:
Model predicting survival in stage I melanoma based on tumor
progression. J Natl Cancer Inst. 81:1893–1904. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guerry D IV, Synnestvedt M, Elder DE and
Schultz D: Lessons from tumor progression: The invasive radial
growth phase of melanoma is common, incapable of metastasis and
indolent. J Invest Dermatol. 100(Suppl): S342–S345. 1993.
View Article : Google Scholar
|
|
4
|
Liu W, Dowling JP, Murray WK, McArthur GA,
Thompson JF, Wolfe R and Kelly JW: Rate of growth in melanomas:
Characteristics and associations of rapidly growing melanomas. Arch
Dermatol. 142:1551–1558. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grob JJ, Richard MA, Gouvernet J, Avril
MF, Delaunay M, Wolkenstein P, Souteyrand P, Bonerandi JJ, Machet
L, Guillaume JC, et al: The kinetics of the visible growth of a
primary melanoma reflects the tumor aggressiveness and is an
independent prognostic marker: A prospective study. Int J Cancer.
102:34–38. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paul E, Pausch A and Bödeker RH: Speed of
growth of melanoma: Statistical analysis of the averages of patient
groups. Pigment Cell Res. 2:475–477. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lipsker D: Growth rate, early detection
and prevention of melanoma: Melanoma epidemiology revisited and
future challenges. Arch Dermatol. 142:1638–1640. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedman RJ, Rigel DS and Kopf AW: Early
detection of malignant melanoma: The role of physician examination
and self-examination of the skin. CA Cancer J Clin. 35:130–151.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barnhill RL, Fine JA, Roush GC and Berwick
M: Predicting five-year outcome for patients with cutaneous
melanoma in a population-based study. Cancer. 78:427–432. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Balch CM: Cutaneous melanoma: Prognosis
and treatment results worldwide. Semin Surg Oncol. 8:400–414. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
A nationwide survey of observer variation
in the diagnosis of thin cutaneus malignant melanoma including the
MIN terminology. CRC Melanoma Pathology Panel. J Clin Pathol.
50:202–205. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McDermott NC, Hayes DP, al-Sader MH, Hogan
JM, Walsh CB, Kay EW and Leader MB: Identification of vertical
growth phase in malignant melanoma. A study of interobserver
agreement. Am J Clin Pathol. 110:753–757. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heenan PJ and Holman CD: Nodular malignant
melanoma: A distinct entity or a common end stage? Am J
Dermatopathol. 4:477–478. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Laga AC and Murphy GF: Cellular
heterogeneity in vertical growth phase melanoma: Arch Pathol Lab
Med. 134:1750–1757. 2010.
|
|
16
|
Lin MJ, Mar V, McLean C and Kelly JW: An
objective measure of growth rate using partial biopsy specimens of
melanomas that were initially misdiagnosed. J Am Acad Dermatol.
71:691–697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tejera-Vaquerizo A, Barrera-Vigo MV,
López-Navarro N and Herrera-Ceballos E: Growth rate as a prognostic
factor in localized invasive cutaneous melanoma. J Eur Acad
Dermatol Venereol. 24:147–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nikolaou VA, Sypsa V, Gogas H, Polydorou
D, Hasapi V, Gagari E and Stratigos A: Evaluation of self-assessed
melanoma growth rate in a Mediterranean patient population.
Melanoma Res. 21:560–562. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gimotty PA, Van Belle P, Elder DE, Murry
T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P and Guerry
D: Biologic and prognostic significance of dermal Ki67 expression,
mitoses and tumorigenicity in thin invasive cutaneous melanoma. J
Clin Oncol. 23:8048–8056. 2005. View Article : Google Scholar : PubMed/NCBI
|
